Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Receivables: 2021-2024

Historic Receivables for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $132.0 million.

  • LifeStance Health's Receivables fell 2344.95% to $121.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.1 million, marking a year-over-year decrease of 2344.95%. This contributed to the annual value of $132.0 million for FY2024, which is 508.2% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's Receivables is $132.0 million, which was up 508.2% from $125.6 million recorded in FY2023.
  • LifeStance Health's 5-year Receivables high stood at $132.0 million for FY2024, and its period low was $95.3 million during FY2021.
  • For the 4-year period, LifeStance Health's Receivables averaged around $113.6 million, with its median value being $113.6 million (2022).
  • In the last 5 years, LifeStance Health's Receivables surged by 2377.35% in 2023 and then soared by 508.2% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Receivables stood at $95.3 million in 2021, then grew by 6.46% to $101.5 million in 2022, then increased by 23.77% to $125.6 million in 2023, then rose by 5.08% to $132.0 million in 2024.
  • Its last three reported values are $132.0 million in FY2024, $125.6 million for FY2023, and $101.5 million during FY2022.